Is the Kaolin or Celite activated clotting time affected by tranexamic acid?

Annals of Thoracic Surgery

Volumn 74, Issue 2, 2002, Pages 390-393

  Bechtel, J F Matthias ^a   Prosch, Joachim ^a   Sievers, Hans Hinrich ^a   Bartels, Claus ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Klinik fur Herzchirurgie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOCHROM 401; HEMOTECH; HEPARIN; INFUSORIAL EARTH; KAOLIN; PROTAMINE; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; HUMAN; IN VITRO STUDY; MALE; PRIORITY JOURNAL; SKIN INCISION;

AGED; ANTIFIBRINOLYTIC AGENTS; DIATOMACEOUS EARTH; FEMALE; HUMANS; MALE; PARTIAL THROMBOPLASTIN TIME; TRANEXAMIC ACID;

EID: 0036321999     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)03744-X     Document Type: Article

References (18)

1. Tranexamic acid: A review of its use in surgery and other indications
2. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: Effects on perioperative bleeding and allogenic transfusions
3. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery
4. Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: Similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients
5. Drugs to minimize perioperative blood loss in cardiac surgery. Meta-analyses using perioperative blood transfusion as the outcome
6. Aprotinin: An update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery
7. The antithrombotic and antiinflammatory mechanisms of action of aprotinin
8. The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement
9. Increased anticoagulation during cardiopulmonary bypass by aprotinin
10. Effect of Celite and kaolin on activated clotting time in the presence of aprotinin: Activated clotting time is reduced by binding of aprotinin to kaolin
11. In vitro effects of aprotinin on activated clotting time measured with different activators
12. Quantitative evaluation of hypothermia, hyperthermia, and hemodilution on coagulation
13. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass
14. Preservation of collagen-induced whole blood platelet aggregation by tranexamic acid therapy in primary cardiac valve surgery
15. Effects of tranexamic acid and aprotinin, two antifibrinolytic drugs, on PAF-induced plasma extravasation in unanesthetized rats
16. Auswirkung von aprotinin und tranexamsäure auf die fibrinolyse und thrombinbildung bei extrakorporaler zirkulation
17. Comparison of blood-conservation strategies in cardiac surgery patients at high risk for bleeding
18. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: An update